This site is intended for healthcare professionals only
LoginRegister
Submit Justification and Rational: CDSCO Panel tells Pfizer on protocol amendment proposal for PalbociclibSubmit Justification and Rational: CDSCO Panel tells Pfizer on protocol amendment proposal for...
Provide GST exemption on import of pharma products used in life-saving medicines research: Parliamentary panel asks CentreProvide GST exemption on import of pharma products used in life-saving medicines research:...
Aurobindo Pharma arm API facility gets 3 observations from USFDAUSFDA issues EIR for Aurobindo Pharma arm AP facility
Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSKJemperli plus Zejula combo significantly improved progression-free survival in primary advanced or...
GSK, Pfizer resolve patent lawsuit over RSV vaccinesPfizer, BioNTech sues Poland, Hungary over Covid debts
Roche Xolair gets USFDA priority review for children, adults with food allergiesRoche Xolair gets USFDA priority review for children, adults with food allergies
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USAJB Pharma enters Opthalmology space, signs Rs 1,089 crore deal with Novartis for 10 brands
Lupin gets CDSCO Panel nod for Rifapentine Dispersible Tablet 150 mgLupin gets CDSCO Panel nod for Rifapentine Dispersible Tablet 150 mg
Conduct BE study and clinical trial: CDSCO Panel tells Cipla on Formoterol Fumarate Dihydrate, glycopyrronium inhalerConduct BE study and clinical trial: CDSCO Panel tells Cipla on Formoterol Fumarate Dihydrate,...
Sanofi India ropes in Himanshu Bakshi as General Manager for Consumer Healthcare businessSanofi India ropes in Himanshu Bakshi as General Manager for Consumer Healthcare business
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus Lifesciences arm Zydus Noveltech dissolves
Sun Pharma Told to Revise Delafloxacin Phase III Trial ProtocolSun Pharma to buy 16.7 percent stake in Lyndra Therapeutics for Rs 249 crore
X